SCHEMBL18285473

SCHEMBL18285473

Nc1nccc2[nH]c(=O)n([C@@H]3CCCNC3)c12

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 11/20 0.40
▸ JAK3 P52333 10/20 0.40
▸ JAK1 P23458 10/20 0.40
▸ HTR3E A5X5Y0 1/20 0.39
▸ HTR3B O95264 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ HTR3A P46098 1/20 0.39
▸ TMEM97 Q5BJF2 1/20 0.39
▸ HTR3D Q70Z44 1/20 0.39
▸ HTR3C Q8WXA8 1/20 0.39
▸ ROCK1 Q13464 2/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ RPS6KA5 O75582 1/20 0.39
▸ BTK Q06187 2/20 0.37
▸ TYK2 P29597 2/20 0.36
▸ HTR6 P50406 1/20 0.35
▸ MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18818255 0.81 RPS6KA5 (0.43) JAK2JAK3JAK1HTR3EHTR3B
SCHEMBL30866992 0.81 RPS6KA5 (0.43) JAK2JAK3JAK1HTR3EHTR3B
SCHEMBL18289975 0.81 RPS6KA5 (0.43) JAK2JAK3JAK1HTR3EHTR3B
SCHEMBL18843035 0.74 BTK (0.58) BTK
SCHEMBL30970924 0.73 EGFR (0.56) JAK2JAK3JAK1BTK
SCHEMBL2104869 0.72 JAK2 (0.79) JAK2JAK3JAK1TYK2
SCHEMBL29614483 0.72 TLR7 (0.41) HTR3EHTR3BHTR2BHTR3ATMEM97
Hydrochloric Acid SCHEMBL2104724 0.71 JAK2 (0.77) JAK2JAK3JAK1TYK2
SCHEMBL6584642 0.71 CHRM2 (0.61) MAPK1
Hydrochloric Acid SCHEMBL11203042 0.70 CHRM2 (0.60) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3303334-A1 TYROSINE KINASE INHIBITORS Principia Biopharma Inc. (US) 2018-04-11 — — EP disclosed
WO-2016196840-A1 TYROSINE KINASE INHIBITORS PRINCIPIA BIOPHARMA INC. (US) 2016-12-08 — — WO disclosed
Send feedback